Carrascosa, A <br/><br/>
The exon 3-deleted/full-length growth hormone receptor polymorphism did not influence growth response to growth hormone therapy over two years in prepubertal short children born at term with adequate weight and length for gestational age.  [electronic resource] 

 -  The Journal of clinical endocrinology and metabolism  Mar 2008 
 - 764-70 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0021-972X 
<br/><br/><label>Standard No.: </label>10.1210/jc.2007-2180  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Birth Weight<br/>Body Height--drug effects<br/>Child<br/>Child, Preschool<br/>Exons<br/>Female<br/>Genotype<br/>Growth Disorders--drug therapy<br/>Growth Hormone--therapeutic use<br/>Hormone Replacement Therapy<br/>Human Growth Hormone--blood<br/>Humans<br/>Infant, Newborn<br/>Male<br/>Polymorphism, Genetic<br/>Receptors, Somatotropin--genetics<br/>Retrospective Studies